Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2Carcinoma, Basal Cell 2Tongue Neoplasms 1Sezary Syndrome 1Pancreatic Neoplasms 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoid Interstitial Pneumonia 1Keratosis, Actinic 1Basal Cell Nevus Syndrome 1

Interventions

fludarabine phosphate 23Peripheral Blood Stem Cell Transplantation 19Whole-Body Irradiation 18Mycophenolic Acid 16Cyclophosphamide 15Busulfan 15Tacrolimus 14Antilymphocyte Serum 14Cyclosporine 11Melphalan 10Rituximab 9Methotrexate 9Etoposide 8romidepsin 6Flow Cytometry 6Filgrastim 6Vorinostat 5Dexamethasone 5thymoglobulin 4fludarabine 4Sirolimus 4Granulocyte Colony-Stimulating Factor 4Carboplatin 4Calcium Dobesilate 4Bexarotene 4Alemtuzumab 4Thiotepa 3Therapeutics 3Radiotherapy 3Panobinostat 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Lymphoma, T-Cell, Cutaneous × 1-phenyl-3,3-dimethyltriazene × Clear all
NCT01800838 2019-05-16

Silicon Phthalocyanine 4 and Photodynamic Therapy in Stage IA-IIA Cutaneous T-Cell Non-Hodgkin Lymphoma

Case Comprehensive Cancer Center

Phase 1 Completed
11 enrolled 10 charts
DermatologicLymphoid

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡